Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept.

ABSTRACT:

SUBMITTER: Rodriguez CI 

PROVIDER: S-EPMC5304999 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature